Publications by authors named "Paula Codo"

Claim this Profile
P
Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma.
Thomas Eigentler, Ioannis Thomas, Igor Samoylenko, Michael Erdmann, Lucie Heinzerling

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3, randomised, observer-blinded, placebo controlled-trial evaluating the safety and immunogenicity of investigational SARS-CoV-2 mRNA vaccine CVnCoV in adult healthcare workers in Mainz (Germany).
Frank Kowalzik, Daniel Teschner, Margarida Mesquita, Christian Jensen, Daniel Schreiner

Vaccine X· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer.
Sebastian M Dieter, Christine Siegl, Paula L Codó, Mario Huerta, Anna L Ostermann-Parucha

Cell Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Fusions in Wild-Type Pancreatic Cancer.
Christoph Heining, Peter Horak, Sebastian Uhrig, Paula L Codo, Barbara Klink

Cancer Discov· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selenite and methylseleninic acid epigenetically affects distinct gene sets in myeloid leukemia: A genome wide epigenetic analysis.
Prajakta Khalkar, Hani Abdulkadir Ali, Paula Codó, Nuria Díaz Argelich, Anni Martikainen

Free Radic Biol Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A ribonucleotide reductase inhibitor with deoxyribonucleoside-reversible cytotoxicity.
Mikael Crona, Paula Codó, Venkateswara Rao Jonna, Anders Hofer, Aristi P Fernandes

Mol Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of glioma cell migration and invasiveness by GDF-15.
Paula Codó, Michael Weller, Kerstin Kaulich, Daniel Schraivogel, Manuela Silginer

Oncotarget· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients.
Patrick Roth, Andreas Keller, Jörg D Hoheisel, Paula Codo, Andrea S Bauer

Eur J Cancer· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.
Paula Codo, Michael Weller, Gunter Meister, Emese Szabo, Alexander Steinle

Oncotarget· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis